This inventor holds 1 USPTO granted patent. Top assignee: Medicines for Malaria Venture (Mmv). Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations in Antimalarial Treatments by Inventor Tirayut Vilaivan
Introduction: Tirayut Vilaivan is a prominent inventor based in Patumwan, Thailand, known for his contributions to the field of medicinal chemistry. His innovative work has led to the development of novel antimalarial compounds, addressing a critical public health challenge posed by malaria.
Latest Patents: Vilaivan holds a patent for "Antimalarial compounds with flexible side-chains." This groundbreaking invention focuses on compounds that act as inhibitors of both wild type and mutant dihydrofolate reductase (DHFR). These compounds are significant as they present a promising approach for the treatment of malaria, demonstrating low toxicity to hosts infected with the malarial parasite and exhibiting potency when formulated in pharmaceutical compositions.
Career Highlights: Tirayut Vilaivan's career is marked by his dedication to developing effective treatments for infectious diseases. His role at Medicines for Malaria Venture (MMV) allows him to contribute to vital research and development aimed at combating malaria, a disease that continues to affect millions globally.
Collaborations: Throughout his career, Vilaivan has collaborated with notable scientists, including Yongyuth Yuthavong and Sumalee Kamchonwongpaisan. These partnerships have been instrumental in enhancing the scope and impact of his research, fostering advancements in antimalarial therapeutics.
Conclusion: With his innovative spirit and commitment to improving healthcare, Tirayut Vilaivan continues to make significant strides in the development of antimalarial treatments. His patents underscore the potential for new compounds to provide effective and safe alternatives in malaria treatment, reflecting his contributions to the ongoing fight against this global health threat.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile